AlloSource Announces Dean Elliott as New President and CEO


Centennial, Colo. — October 19, 2022 — AlloSource, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, announced today AlloSource Chief Operating and Legal Officer, Dean Elliott, has been selected as the…


AlloSource Announces Award from the U.S. Government to Supply Allograft Skin for Crisis Preparedness in the Event Of Mass Casualty Burn Incidents


Centennial, Colo. — October 12, 2022 — AlloSource®, one of the largest allograft providers in the U.S., today announced it was awarded a multi-year contract by the Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response…


AlloSource Announces New Partnership with St. Mary’s Grand Junction as Part of its Placenta Donation Program


Centennial, Colo. — September 26, 2022 — AlloSource, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, is proud to announce the expansion of its AlloSource Placental Donation Program into Grand Junction,…


Dr. Todd Huzar Recognized By Allosource With The Annual Dr. Steven Gitelis Inspiration Award For His Work With Burn Survivors


Centennial, Colo. — August 30, 2022 — Burn Surgeon Dr. Todd Huzar was recognized by AlloSource®, one of the largest allograft providers in the U.S., with its sixth annual Dr. Steven Gitelis Inspiration Award, which honors a physician who understands and embraces the use of donated human tissue,…


AlloSource Announces President and CEO Retirement


Centennial, Colo. — August 2, 2022 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue allografts to help surgeons heal their patients, today announced President and CEO, Tom Cycyota, plans to retire. Cycyota has been in his role since 2000,…


AlloSource® Adds Quadricep Tendons To Its AlloConnex™ Line Of Tendons, Ligaments And Fascia


Centennial, Colo. — July 12, 2022 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue allografts to help surgeons heal their patients, today announced the addition of a quadricep tendon to its AlloConnex™ line of tendons, ligaments and fascia.…


AlloSource® Announces New Micro Fibers Demineralized Bone Allograft


Centennial, Colo. — June 28, 2022 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue allografts to help surgeons heal their patients, today announced the addition of AlloFuse® Micro Fibers Demineralized Bone allograft for use in spinal, foot…


AlloSource Sponsored DeVaughn Levy-Hagan Memorial Basketball Game Raises Money For Mental Health/Suicide Prevention


Centennial, Colo. — April 27, 2022 — AlloSource®, Colorado’s largest homegrown bioscience company whose business focuses on creating innovative cellular and tissue allografts to help surgeons heal their patients, sponsored the DeVaughn Levy-Hagan Memorial Basketball Game for Mental Health/Suicide…


Allosource Recognized As The Top Colorado Bioscience Manufacturer


Centennial, Colo. — April 12, 2022 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, has been recognized as 2022 Bioscience Manufacturer of the Year by CompanyWeek’s Colorado Manufacturing Awards…


AlloSource’s Cartilage Allograft Expertise To Be Featured At The International Cartilage Regeneration & Joint Preservation Society Annual Meeting


Centennial, Colo. — April 5, 2022 — AlloSource®, one of the largest allograft providers creating innovative cellular and tissue allografts to help surgeons heal their patients, today announced scientific data supporting the company’s cartilage allograft technology will be featured at the…


AlloSource Launches AlloMend Extra-Large Acellular Dermal Matrix – New Dermal Graft has the Largest Footprint Within the AlloMend Product Line to Support Demanding Soft Tissue Applications in Plastic and Reconstructive Surgery


Centennial, Colo. — October 27, 2021 — AlloSource®, one of the largest allograft providers in the U.S. creating innovative cellular and tissue products to help surgeons heal their patients, today announced the launch of AlloMend® Extra-Large (XL) Acellular Dermal Matrix (ADM), the newest addition…


AlloSource Launches AlloMend Ultra-Thick Acellular Dermal Matrix New Allograft Is The Thickest In The AlloMend Product Line To Support Demanding Soft Tissue Applications


Centennial, Colo. — August 11, 2021 — AlloSource®, one of the largest allograft providers in the U.S. creating innovative cellular and tissue products to help surgeons heal their patients, today announced the launch of AlloMend® Ultra-Thick Acellular Dermal Matrix (ADM), the newest addition to the…


AlloSource Honors Dr. David Argo With The Annual Dr. Steven Gitelis Inspiration Award


Centennial, Colo. — June 9, 2021 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, today announced it is awarding Dr. David Argo with its fifth annual Dr. Steven Gitelis Inspiration Award. The…


Study On The Biomechanical Properties of Dermal Matrices Published In Plastic And Reconstructive Surgery—Global Open Finds AlloSource’s Meshed AlloMend Has Superior Fluid Egress Properties


Centennial, Colo. — June 2, 2021 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, today announced Plastic and Reconstructive Surgery—Global Open published the findings of a study titled “The…


AlloSource Announces First Patients Implanted With AlloWrap Amniotic Membrane In Clinical Study For Two-Level Anterior Cervical Discectomy And Fusion Procedures


Centennial, Colo. — February 23, 2021 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products, today announced the first patients have been enrolled in its clinical study titled, A Randomized, Controlled Study to Evaluate Effectiveness of…


AlloSource’s ProChondrix CR, Cryopreserved Osteochondral Allograft, To Be Featured At The British Patellofemoral Society Meeting


Centennial, Colo. — November 15, 2020 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products, today announced its ProChondrix® CR allograft, will be featured in a presentation by Dr. David Argo at the British Patellofemoral Society…


AlloSource Commits Multi-Year Financial Support To Phoenix Society For Burn Survivors


The generous donation will support burn survivor healing through major initiatives surrounding patient and family care, virtual programming and peer support Centennial, Colo. — December 22, 2020 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and…


Science Behind AlloSource’s Cryopreserved Cartilage Published In Journal Of Orthopaedic Surgery And Research


Peer review describes the data behind ProChondrix CR’s ability to maintain the functional components of healthy cartilage after two years of cryopreserved storage Centennial, Colo. — December 8, 2020 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular…


AlloSource Receives Gold Level Recognition For Workplace Health Achievement From The American Heart Association Three Years In A Row


Centennial, Colo. — November 24, 2020 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, today announced it received Gold level recognition from the American Heart Association for continuing to…


AlloSource Announces First Patients Complete 12-Month Milestone In ProChondrix CR Clinical Study For Cartilage Defects In The Knee


Centennial, Colo. — November 17, 2020 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products, today announced its first patients have completed their 12-month follow-up in its five-year study titled, A Prospective, Multi-Center Study…


AlloSource Honors Dr. Ergun Kocak With The Annual Dr. Steven Gitelis Inspiration Award


Centennial, Colo. — August 4, 2020 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, today announced it is awarding Dr. Ergun Kocak with its fourth annual Dr. Steven Gitelis Inspiration Award.…


AlloSource Names Tendon and Ligament Portfolio Under New Brand AlloConnex


Centennial, Colo. — July 23, 2020 — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue allografts to help surgeons heal their patients, today announced it is naming its tendon and ligament portfolio under the new brand AlloConnex™. “Over the…


Research Shows ProChondrix CR Maintains Consistent, High Cell Viability For Two Years


Proprietary cryopreservation technique of thin, laser-etched osteochondral allografts provides longer shelf-life, expanding access for cartilage treatment Centennial, Colo. — October 7, 2019 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells…


AlloSource Celebrates 25 Years of Doing More With Life


Milestone highlights organization’s growth into one of the largest tissue banks in the U.S. Centennial, Colo. — August 9, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, will be celebrating 25 years of honoring donors…